Fundz

Syner-G BioPharma Group Appoints Scott Bergeron as Chief Commercial Officer

PRIVATEApr 08, 2025

Position

Chief Commercial Officer

Company

Syner-G BioPharma Group

Scott Bergeron
scott.bergeron@synergbiopharma.com
BostonBiotechnologyConsultingLife Science

Description

Syner-G BioPharma Group and Sequoia Biotech Consulting announce the appointment of Scott Bergeron as Chief Commercial Officer. His extensive experience in life sciences consulting and commitment to client success will enhance the company's commercial strategy.

Quick answer

Syner-G BioPharma Group Appoints Scott Bergeron as Chief Commercial Officer (April 8, 2025). Syner-G BioPharma Group is based in Boston, Massachusetts, United States.

Who is the new Chief Commercial Officer at Syner-G BioPharma Group?
Syner-G BioPharma Group named Scott Bergeron Chief Commercial Officer, announced April 8, 2025.
What did Syner-G BioPharma Group announce on April 8, 2025?
Syner-G BioPharma Group and Sequoia Biotech Consulting announce the appointment of Scott Bergeron as Chief Commercial Officer. His extensive experience in life sciences consulting and commitment to client success will enhance the company's commercial strategy.
What does Syner-G BioPharma Group do?
Syner-G BioPharma Group provides in-depth expertise across the three key elements of Chemistry, Manufacturing, and Controls (CMC): Regulatory Services, Technical Development, and Quality/IT.
Where is Syner-G BioPharma Group based?
Syner-G BioPharma Group is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
The Royal Society of Biology (April 8, 2025), Freenome (April 9, 2025), Biolyst Scientific (April 4, 2025) and LabCentral (April 3, 2025) also announced leadership changes within 45 days of Syner-G BioPharma Group.

Source: Fundz verified event record.

Other recent leadership changes in Consulting and Life Science

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Syner-G BioPharma Group, and when

A new leader at Syner-G BioPharma Group brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Syner-G BioPharma Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syner-G BioPharma Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syner-G BioPharma Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syner-G BioPharma Group

Location

Boston, Massachusetts, United States

About

Syner-G BioPharma Group provides in-depth expertise across the three key elements of Chemistry, Manufacturing, and Controls (CMC): Regulatory Services, Technical Development, and Quality/IT. We call this CMC 360™. We also provide medical writing services, with expertise in authoring a variety of regulatory documents across a wide range of therapeutic areas and in all phases of development. Our regulatory affairs services include the development and implementation of global regulatory strategic plans, regulatory agency meeting support, and electronic submissions to regulatory authorities around the world. We have the skill set and experience to guide your prime asset through any development challenges and along the ever-changing maze of regulatory filing pathways, to a position of full compliance, and high quality. Our expertise spans small molecules, peptides, oligonucleotides, biologics, monoclonal antibodies, antibody-drug conjugates, and cell and gene therapy products.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syner-G BioPharma Group changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chris
Likely contact at this company
••••••••@••••••••

See Chris's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Syner-G BioPharma Group's next move

Learn about Strategic plan

Syner-G BioPharma Group changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.